Swedish Orphan Biovitrum Ab (publ)
(OTC) BIOVF
Swedish Orphan Biovitrum Ab (publ) Financials at a Glance
Market Cap
$16.60B
Revenue (TTM)
SEK 28.88B
Net Income (TTM)
SEK 936.33M
EPS (TTM)
$0.29
P/E Ratio
160.37
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Price
$48.00
Volume
2,000
Open
$48.00
Price
$48.00
Volume
2,000
Open
$48.00
Previous Close
$48.00
Daily Range
$48.00 - $48.00
52-Week Range
$28.94 - $48.00
Estimated Earnings Date
Jul 16, 2026
Dividend
$0.00
Beta (Volatility)
0.18 (Low)
Price
$48.00
Volume
2,000
Open
$48.00
Previous Close
$48.00
Daily Range
$48.00 - $48.00
52-Week Range
$28.94 - $48.00
Estimated Earnings Date
Jul 16, 2026
BIOVF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Swedish Orphan Biovitrum Ab (publ)
Industry
Biotechnology
Sector
Health CareEmployees
1,969
CEO
Guido Oelkers, PhD
Website
www.sobi.comHeadquarters
Solna, 112 76, SE
BIOVF Financials
Key Financial Metrics (TTM)
Gross Margin
44.17%
Operating Margin
29.56%
Net Income Margin
3.18%
Return on Equity
2.41%
Return on Capital
16.34%
Return on Assets
1.13%
Earnings Yield
0.62%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.60B
Shares Outstanding
345.85M
Volume
2.00K
Avg. Volume
47.871
Financials (TTM)
Gross Profit
SEK 14.51B
Operating Income
SEK 8.05B
EBITDA
SEK 11.31B
Operating Cash Flow
SEK 7.37B
Capital Expenditure
-SEK 687.99M
Free Cash Flow
SEK 6.69B
Cash & ST Invst.
SEK 940.00M
Total Debt
SEK 19.06B
Swedish Orphan Biovitrum Ab (publ) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
SEK 7.18B
+11.1%
Gross Profit
SEK 5.44B
+11.5%
Gross Margin
75.69%
N/A
Market Cap
$16.60B
N/A
Market Cap/Employee
$8.76M
N/A
Employees
1,895
N/A
Net Income
SEK 1.32B
+50.6%
EBITDA
SEK 2.65B
+15.4%
Quarterly Fundamentals
Total Cash
SEK 940.00M
-5.7%
Total Debt
SEK 19.06B
+35.9%
Accounts Receivable
SEK 9.28B
+35.7%
Inventory
SEK 5.08B
+30.8%
Long Term Debt
SEK 7.91B
-21.0%
Short Term Debt
SEK 11.15B
+177.9%
Return on Assets
1.13%
N/A
Return on Invested Capital
14.37%
N/A
Free Cash Flow
SEK 872.00M
-61.8%
Operating Cash Flow
SEK 1.13B
-50.9%